ES2729838T3 - Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo - Google Patents

Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo Download PDF

Info

Publication number: ES2729838T3
Authority: ES; Spain
Prior art keywords: virus; prrs; nucleic acid; seq; amino acid
Prior art date: 2013-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES14827219T

Other languages

English (en)

Spanish (es)

Inventor

Andreas Gallei

Christoph Keller

Erik Schacht

Marieke Herrel

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Vetmedica GmbH

Original Assignee

Boehringer Ingelheim Vetmedica GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-20

Filing date

2014-12-19

Publication date

2019-11-06

2014-12-19 Application filed by Boehringer Ingelheim Vetmedica GmbH filed Critical Boehringer Ingelheim Vetmedica GmbH

2019-11-06 Application granted granted Critical

2019-11-06 Publication of ES2729838T3 publication Critical patent/ES2729838T3/es

Status Active legal-status Critical Current

2034-12-19 Anticipated expiration legal-status Critical

Links

241000700605 Viruses Species 0.000 title claims abstract description 350
208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 title claims abstract description 252
239000002299 complementary DNA Substances 0.000 title description 27
150000007523 nucleic acids Chemical class 0.000 claims abstract description 157
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 81
102000039446 nucleic acids Human genes 0.000 claims abstract description 81
108020004707 nucleic acids Proteins 0.000 claims abstract description 81
108020004414 DNA Proteins 0.000 claims description 53
241001465754 Metazoa Species 0.000 claims description 31
241000282887 Suidae Species 0.000 claims description 23
230000002238 attenuated effect Effects 0.000 claims description 23
239000000203 mixture Substances 0.000 claims description 21
238000000034 method Methods 0.000 claims description 20
102000053602 DNA Human genes 0.000 claims description 18
238000011282 treatment Methods 0.000 claims description 8
238000011321 prophylaxis Methods 0.000 claims description 7
239000003085 diluting agent Substances 0.000 claims description 6
239000000546 pharmaceutical excipient Substances 0.000 claims description 6
210000004027 cell Anatomy 0.000 description 148
241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 118
125000003275 alpha amino acid group Chemical group 0.000 description 114
101100028161 Porcine circovirus 2 ORF4 gene Proteins 0.000 description 105
208000015181 infectious disease Diseases 0.000 description 89
235000001014 amino acid Nutrition 0.000 description 74
125000000539 amino acid group Chemical group 0.000 description 48
108091032973 (ribonucleotides)n+m Proteins 0.000 description 45
230000008030 elimination Effects 0.000 description 35
238000003379 elimination reaction Methods 0.000 description 35
230000002458 infectious effect Effects 0.000 description 31
239000002773 nucleotide Substances 0.000 description 29
125000003729 nucleotide group Chemical group 0.000 description 28
238000012217 deletion Methods 0.000 description 26
230000037430 deletion Effects 0.000 description 26
229960005486 vaccine Drugs 0.000 description 25
150000001413 amino acids Chemical class 0.000 description 24
108010050904 Interferons Proteins 0.000 description 23
102000014150 Interferons Human genes 0.000 description 23
229940079322 interferon Drugs 0.000 description 23
238000004519 manufacturing process Methods 0.000 description 21
241000710788 Lelystad virus Species 0.000 description 20
230000035772 mutation Effects 0.000 description 16
108090000623 proteins and genes Proteins 0.000 description 16
230000028993 immune response Effects 0.000 description 15
230000000120 cytopathologic effect Effects 0.000 description 14
230000003612 virological effect Effects 0.000 description 14
108090000288 Glycoproteins Proteins 0.000 description 13
102000003886 Glycoproteins Human genes 0.000 description 13
238000003780 insertion Methods 0.000 description 13
230000037431 insertion Effects 0.000 description 13
230000000670 limiting effect Effects 0.000 description 13
239000002243 precursor Substances 0.000 description 13
101150000233 ORF4 gene Proteins 0.000 description 12
230000012010 growth Effects 0.000 description 12
101800000120 Host translation inhibitor nsp1 Proteins 0.000 description 11
101800000512 Non-structural protein 1 Proteins 0.000 description 11
230000001939 inductive effect Effects 0.000 description 11
230000003472 neutralizing effect Effects 0.000 description 11
102000004169 proteins and genes Human genes 0.000 description 11
238000012360 testing method Methods 0.000 description 11
238000002474 experimental method Methods 0.000 description 10
244000052769 pathogen Species 0.000 description 10
235000018102 proteins Nutrition 0.000 description 10
101000621943 Acholeplasma phage L2 Probable integrase/recombinase Proteins 0.000 description 9
101000618348 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) Uncharacterized protein Alvin_0065 Proteins 0.000 description 9
101000781117 Autographa californica nuclear polyhedrosis virus Uncharacterized 12.4 kDa protein in CTL-LEF2 intergenic region Proteins 0.000 description 9
101000708323 Azospirillum brasilense Uncharacterized 28.8 kDa protein in nifR3-like 5'region Proteins 0.000 description 9
101000770311 Azotobacter chroococcum mcd 1 Uncharacterized 19.8 kDa protein in nifW 5'region Proteins 0.000 description 9
101000748761 Bacillus subtilis (strain 168) Uncharacterized MFS-type transporter YcxA Proteins 0.000 description 9
101000765620 Bacillus subtilis (strain 168) Uncharacterized protein YlxP Proteins 0.000 description 9
101000916134 Bacillus subtilis (strain 168) Uncharacterized protein YqxJ Proteins 0.000 description 9
101000754349 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) UPF0065 protein BP0148 Proteins 0.000 description 9
101000827633 Caldicellulosiruptor sp. (strain Rt8B.4) Uncharacterized 23.9 kDa protein in xynA 3'region Proteins 0.000 description 9
101000947628 Claviceps purpurea Uncharacterized 11.8 kDa protein Proteins 0.000 description 9
101000686796 Clostridium perfringens Replication protein Proteins 0.000 description 9
101000788129 Escherichia coli Uncharacterized protein in sul1 3'region Proteins 0.000 description 9
101000788370 Escherichia phage P2 Uncharacterized 12.9 kDa protein in GpA 3'region Proteins 0.000 description 9
101000787096 Geobacillus stearothermophilus Uncharacterized protein in gldA 3'region Proteins 0.000 description 9
101000976889 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 19.2 kDa protein in cox-rep intergenic region Proteins 0.000 description 9
101000827627 Klebsiella pneumoniae Putative low molecular weight protein-tyrosine-phosphatase Proteins 0.000 description 9
101001130841 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF5 Proteins 0.000 description 9
101000974028 Rhizobium leguminosarum bv. viciae (strain 3841) Putative cystathionine beta-lyase Proteins 0.000 description 9
101000756519 Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) Uncharacterized protein RCAP_rcc00048 Proteins 0.000 description 9
101000948219 Rhodococcus erythropolis Uncharacterized 11.5 kDa protein in thcD 3'region Proteins 0.000 description 9
101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 9
101000929863 Streptomyces cinnamonensis Monensin polyketide synthase putative ketoacyl reductase Proteins 0.000 description 9
101000788468 Streptomyces coelicolor Uncharacterized protein in mprR 3'region Proteins 0.000 description 9
101000845085 Streptomyces violaceoruber Granaticin polyketide synthase putative ketoacyl reductase 1 Proteins 0.000 description 9
241000282898 Sus scrofa Species 0.000 description 9
101000711771 Thiocystis violacea Uncharacterized 76.5 kDa protein in phbC 3'region Proteins 0.000 description 9
101000711318 Vibrio alginolyticus Uncharacterized 11.6 kDa protein in scrR 3'region Proteins 0.000 description 9
238000004113 cell culture Methods 0.000 description 9
239000012228 culture supernatant Substances 0.000 description 9
239000003814 drug Substances 0.000 description 9
230000001717 pathogenic effect Effects 0.000 description 9
230000009467 reduction Effects 0.000 description 9
102100031725 Cortactin-binding protein 2 Human genes 0.000 description 8
101710197985 Probable protein Rev Proteins 0.000 description 8
206010058874 Viraemia Diseases 0.000 description 8
230000006698 induction Effects 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
230000000694 effects Effects 0.000 description 7
108090000765 processed proteins & peptides Proteins 0.000 description 7
230000001850 reproductive effect Effects 0.000 description 7
239000000427 antigen Substances 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
238000011161 development Methods 0.000 description 6
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
230000002829 reductive effect Effects 0.000 description 6
101150062176 ORF5 gene Proteins 0.000 description 5
210000001744 T-lymphocyte Anatomy 0.000 description 5
238000001514 detection method Methods 0.000 description 5
230000004069 differentiation Effects 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
239000002245 particle Substances 0.000 description 5
239000013612 plasmid Substances 0.000 description 5
230000000241 respiratory effect Effects 0.000 description 5
238000012546 transfer Methods 0.000 description 5
238000002255 vaccination Methods 0.000 description 5
210000003501 vero cell Anatomy 0.000 description 5
108090000565 Capsid Proteins Proteins 0.000 description 4
102100023321 Ceruloplasmin Human genes 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
108700026244 Open Reading Frames Proteins 0.000 description 4
239000005557 antagonist Substances 0.000 description 4
210000003719 b-lymphocyte Anatomy 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
238000003745 diagnosis Methods 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
238000002955 isolation Methods 0.000 description 4
238000006386 neutralization reaction Methods 0.000 description 4
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 4
238000010186 staining Methods 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
239000013598 vector Substances 0.000 description 4
210000002845 virion Anatomy 0.000 description 4
101100165658 Alternaria brassicicola bsc5 gene Proteins 0.000 description 3
101100032924 Bacillus subtilis (strain 168) radA gene Proteins 0.000 description 3
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
101100492392 Didymella fabae pksAC gene Proteins 0.000 description 3
101800000511 Non-structural protein 2 Proteins 0.000 description 3
101100226893 Phomopsis amygdali PaP450-2 gene Proteins 0.000 description 3
210000004899 c-terminal region Anatomy 0.000 description 3
238000010276 construction Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000010790 dilution Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 3
230000002163 immunogen Effects 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
210000004072 lung Anatomy 0.000 description 3
239000003550 marker Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
230000007918 pathogenicity Effects 0.000 description 3
230000008569 process Effects 0.000 description 3
230000001681 protective effect Effects 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000007017 scission Effects 0.000 description 3
230000028327 secretion Effects 0.000 description 3
230000000405 serological effect Effects 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
230000035899 viability Effects 0.000 description 3
229930024421 Adenine Natural products 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical class NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
241000867607 Chlorocebus sabaeus Species 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108010014726 Interferon Type I Proteins 0.000 description 2
102000002227 Interferon Type I Human genes 0.000 description 2
230000004988 N-glycosylation Effects 0.000 description 2
101800000514 Non-structural protein 4 Proteins 0.000 description 2
101150001779 ORF1a gene Proteins 0.000 description 2
-1 ORF1ab Proteins 0.000 description 2
108010076039 Polyproteins Proteins 0.000 description 2
108010003533 Viral Envelope Proteins Proteins 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
108020000999 Viral RNA Proteins 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000004913 activation Effects 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
230000008512 biological response Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
239000000032 diagnostic agent Substances 0.000 description 2
229940039227 diagnostic agent Drugs 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
238000010166 immunofluorescence Methods 0.000 description 2
230000006872 improvement Effects 0.000 description 2
210000005007 innate immune system Anatomy 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
230000003902 lesion Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000002483 medication Methods 0.000 description 2
239000002609 medium Substances 0.000 description 2
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
150000002972 pentoses Chemical class 0.000 description 2
125000001805 pentosyl group Chemical group 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000000047 product Substances 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
238000010188 recombinant method Methods 0.000 description 2
238000010845 search algorithm Methods 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
208000011580 syndromic disease Diseases 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
230000029812 viral genome replication Effects 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
230000001018 virulence Effects 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
101000787132 Acidithiobacillus ferridurans Uncharacterized 8.2 kDa protein in mobL 3'region Proteins 0.000 description 1
101000827262 Acidithiobacillus ferrooxidans Uncharacterized 18.9 kDa protein in mobE 3'region Proteins 0.000 description 1
101000811747 Antithamnion sp. UPF0051 protein in atpA 3'region Proteins 0.000 description 1
241001292006 Arteriviridae Species 0.000 description 1
101000827607 Bacillus phage SPP1 Uncharacterized 8.5 kDa protein in GP2-GP6 intergenic region Proteins 0.000 description 1
101000961975 Bacillus thuringiensis Uncharacterized 13.4 kDa protein Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
101000964407 Caldicellulosiruptor saccharolyticus Uncharacterized 10.7 kDa protein in xynB 3'region Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
101000799969 Escherichia coli (strain K12) Alpha-2-macroglobulin Proteins 0.000 description 1
101150034914 GP2a gene Proteins 0.000 description 1
229920001503 Glucan Polymers 0.000 description 1
101710127406 Glycoprotein 5 Proteins 0.000 description 1
101000768777 Haloferax lucentense (strain DSM 14919 / JCM 9276 / NCIMB 13854 / Aa 2.2) Uncharacterized 50.6 kDa protein in the 5'region of gyrA and gyrB Proteins 0.000 description 1
101000572796 Hepatitis E virus genotype 1 (isolate Human/China/HeBei/1987) RNA-directed RNA polymerase Proteins 0.000 description 1
101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 1
101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
101000607404 Infectious laryngotracheitis virus (strain Thorne V882) Protein UL24 homolog Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
206010056254 Intrauterine infection Diseases 0.000 description 1
101000735632 Klebsiella pneumoniae Uncharacterized 8.8 kDa protein in aacA4 3'region Proteins 0.000 description 1
SPEFJYZGXZENAF-UHFFFAOYSA-N N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide Chemical compound C=1C(C)=CC=C(C2=3)C=1CC=3C(C(=O)NC1CCCCC1)=NN2C1=CC=C(Cl)C=C1Cl SPEFJYZGXZENAF-UHFFFAOYSA-N 0.000 description 1
102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
241001292005 Nidovirales Species 0.000 description 1
108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
101150063292 ORF2a gene Proteins 0.000 description 1
101150084044 P gene Proteins 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102100038411 Platelet glycoprotein V Human genes 0.000 description 1
101710195077 Platelet glycoprotein V Proteins 0.000 description 1
108091036407 Polyadenylation Proteins 0.000 description 1
101900328733 Porcine reproductive and respiratory syndrome virus Glycoprotein 5 Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
101000818100 Spirochaeta aurantia Uncharacterized 12.7 kDa protein in trpE 5'region Proteins 0.000 description 1
101001037658 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) Glucokinase Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
108010067674 Viral Nonstructural Proteins Proteins 0.000 description 1
108700010756 Viral Polyproteins Proteins 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
210000001132 alveolar macrophage Anatomy 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000003042 antagnostic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000000339 bright-field microscopy Methods 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
150000001721 carbon Chemical group 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
230000007123 defense Effects 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000012634 fragment Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
230000036541 health Effects 0.000 description 1
210000002443 helper t lymphocyte Anatomy 0.000 description 1
230000005745 host immune response Effects 0.000 description 1
238000003125 immunofluorescent labeling Methods 0.000 description 1
230000017555 immunoglobulin mediated immune response Effects 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000010468 interferon response Effects 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
230000021633 leukocyte mediated immunity Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000005210 lymphoid organ Anatomy 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000009340 pathogen transmission Effects 0.000 description 1
239000013641 positive control Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
208000023504 respiratory system disease Diseases 0.000 description 1
230000004044 response Effects 0.000 description 1
239000003340 retarding agent Substances 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
230000011664 signaling Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
230000004960 subcellular localization Effects 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
229940125575 vaccine candidate Drugs 0.000 description 1
230000008957 viral persistence Effects 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10041—Use of virus, viral particle or viral elements as a vector
- C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Mycology (AREA)
Analytical Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ES14827219T 2013-12-20 2014-12-19 Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo Active ES2729838T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP13199177		2013-12-20
EP14175691		2014-07-03
PCT/EP2014/078929 WO2015092058A1 (en)	2013-12-20	2014-12-19	Prrs virus variant, european prrs virus cdna clone, and uses thereof

Publications (1)

Publication Number	Publication Date
ES2729838T3 true ES2729838T3 (es)	2019-11-06

Family

ID=52347295

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES14827219T Active ES2729838T3 (es)	2013-12-20	2014-12-19	Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo
ES19165389T Active ES2940691T3 (es)	2013-12-20	2014-12-19	Variante de virus PRRS, clon de ADNc de virus PRRS europeo y usos de los mismos

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES19165389T Active ES2940691T3 (es)	2013-12-20	2014-12-19	Variante de virus PRRS, clon de ADNc de virus PRRS europeo y usos de los mismos

Country Status (13)

Country	Link
US (2)	US10010601B2 (2)
EP (2)	EP3591042B1 (2)
JP (3)	JP6886291B2 (2)
KR (2)	KR102270344B1 (2)
CN (1)	CN105829528B (2)
AU (2)	AU2014369774B2 (2)
CA (1)	CA2930042C (2)
DK (2)	DK3591042T5 (2)
EA (1)	EA039060B1 (2)
ES (2)	ES2729838T3 (2)
HU (1)	HUE061768T2 (2)
MX (2)	MX2020010248A (2)
WO (1)	WO2015092058A1 (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH12013501708B1 (en)	2011-02-17	2018-08-03	Boehringer Ingelheim Vetmedica Gmbh	Commercial scale process for production of prrsv
HRP20151031T1 (hr)	2011-02-17	2015-11-06	Boehringer Ingelheim Vetmedica Gmbh	Novi europski soj prrsv
ES2729838T3 (es)	2013-12-20	2019-11-06	Boehringer Ingelheim Vetmedica Gmbh	Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo
US11332739B2 (en)	2016-08-05	2022-05-17	Hipra Scientific, S.L.U.	Porcine reproductive and respiratory syndrome virus cDNA clone and uses thereof
KR102335864B1 (ko) *	2018-12-27	2021-12-06	주식회사 바이오포아	돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
WO2020138761A1 (ko) *	2018-12-27	2020-07-02	주식회사 바이오포아	돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신
CN119876049A (zh)	2019-08-29	2025-04-25	礼蓝美国公司	猪繁殖与呼吸综合征疫苗病毒
CN110894243B (zh) *	2019-12-16	2021-07-13	中国农业大学	一种猪蓝耳病毒嵌合抗原以及检测猪蓝耳病毒抗体的胶体金免疫层析试纸条
WO2021138447A1 (en)	2019-12-31	2021-07-08	Elixirgen Therapeutics, Inc.	Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
JP2021153692A (ja) *	2020-03-25	2021-10-07	株式会社三共	遊技機
KR102319508B1 (ko) *	2020-07-27	2021-10-28	연세대학교 산학협력단	인체 감염형 낙타 유래 메르스코로나바이러스 검출용 바이오마커 및 이의 용도
CN113969267B (zh) *	2021-11-15	2024-02-27	中国农业大学	一种猪繁殖与呼吸综合征突变病毒及其构建方法与应用
WO2024077281A2 (en) *	2022-10-06	2024-04-11	Cornell University	Genotyping and sequencing assays for prrsv
KR20240146158A (ko) *	2023-03-27	2024-10-08	주식회사 케어사이드	돼지생식기호흡기증후군 키메릭 바이러스 및 이를 이용한 백신 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3137631A (en)	1959-12-01	1964-06-16	Faberge Inc	Encapsulation in natural products
US3959457A (en)	1970-06-05	1976-05-25	Temple University	Microparticulate material and method of making such material
US4015100A (en)	1974-01-07	1977-03-29	Avco Everett Research Laboratory, Inc.	Surface modification
EP0000062A1 (en)	1977-06-07	1978-12-20	Joseph George Spitzer	Vapor tap valve for aerosol containers used with inflammable propellants, and container provided therewith
US4205060A (en)	1978-12-20	1980-05-27	Pennwalt Corporation	Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
DE3687769T2 (de)	1985-07-08	1993-09-02	Chiron Corp	Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
NZ222465A (en)	1986-11-07	1992-11-25	Pasteur Institut	Nanb (non a, non b hepatitis viral) antigen
JP3128133B2 (ja)	1991-06-06	2001-01-29	スティッチティングセントラールディールゲネースクンディグインスティトゥート	豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法
US6042830A (en)	1992-08-05	2000-03-28	Boehringer Ingelheim Vetmedica, Inc.	Viral agent associated with mystery swine disease
AU2684792A (en)	1991-10-14	1993-05-21	Akzo Nobel N.V.	Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (fr)	1992-01-14	1994-12-30	Rhone Merieux	Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en)	1992-10-30	1997-12-09	Iowa State University Research Foundation	Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
ES2074950B1 (es)	1993-09-17	1996-03-16	Iberica Cyanamid	Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
DE69522984T2 (de)	1994-04-11	2002-04-25	Akzo Nobel Nv	Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins
GB2289279B (en)	1994-05-13	1998-09-16	Iberica Cyanamid	Diagnostic kits and vaccines containing recombinant PRRSV proteins
EP0732340B1 (en)	1995-03-14	2004-06-09	Akzo Nobel N.V.	Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
ES2102971B1 (es)	1996-01-25	1998-03-01	Hipra Lab Sa	Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5866401A (en)	1996-03-01	1999-02-02	Schering Corporation	Porcine reproductive and respiratory syndrome vaccine
EP0835930B1 (en)	1996-10-09	2001-01-31	Akzo Nobel N.V.	European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
EP0839912A1 (en)	1996-10-30	1998-05-06	Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo)	Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
US20040224327A1 (en)	1996-10-30	2004-11-11	Meulenberg Johanna Jacoba Maria	Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
KR100388257B1 (ko)	1997-05-06	2003-06-19	스티칭 디엔스트 랜드보위쿤디그 온데조에크	백신 또는 진단방법에서 사용하기 위한 피알알에스 바이러스의 피알알에스브이 항원부위 인식성 펩타이드 서열
CA2290220C (en) *	1998-12-22	2013-11-19	Pfizer Products Inc.	An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
EP1157121B1 (en)	1999-03-08	2013-04-24	Boehringer Ingelheim Vetmedica GmbH	Prrsv replicon
DK2251419T3 (da)	1999-04-22	2012-07-02	Us Agriculture	Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142
WO2002095040A1 (en)	2001-05-21	2002-11-28	Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V.	Delections in arterivirus replicons
WO2001059077A1 (en)	2000-02-08	2001-08-16	Regents Of The University Of Minnesota	Porcine reproductive and respiratory syndrome virus and methods of use
EP1156111A1 (en)	2000-05-19	2001-11-21	Stichting Dienst Landbouwkundig Onderzoek	Chimeric arterivirus-like particles
ATE557082T1 (de)	2002-04-05	2012-05-15	Boehringer Ingelheim Vetmed	Sequenz positionen zur anpassung bei prrsv
US7722878B2 (en)	2004-06-17	2010-05-25	Boehringer Ingelheim Vetmedica, Inc.	PRRSV subunit vaccines
US7632636B2 (en)	2004-09-21	2009-12-15	Boehringer Ingelheim Vetmedica, Inc.	Porcine reproductive and respiratory syndrome isolates and methods of use
RU2007130801A (ru)	2005-01-13	2009-02-20	Берингер Ингельхайм Ветмедика Гмбх (De)	Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs)
WO2008121958A1 (en)	2007-04-02	2008-10-09	Boehringer Ingelheim Vetmedica, Inc.	Use of prrsv vaccines to reduce pcv2 viremia
KR20100058451A (ko) *	2007-06-25	2010-06-03	사우스다코타주립대학	재조합 북아메리카 타입 1 돼지 생식기 및 호흡기 증후군 바이러스 및 이의 사용 방법
EP2328612A4 (en)	2008-08-25	2012-11-14	Boehringer Ingelheim Vetmed	VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS)
WO2010084648A1 (ja) *	2009-01-20	2010-07-29	シャープ株式会社	照明装置、表示装置、及びテレビ受信装置
ES2742262T3 (es)	2010-04-16	2020-02-13	Univ Gent	Vacuna con protección cruzada para el virus del síndrome respiratorio y reproductivo porcino
PH12013501708B1 (en)	2011-02-17	2018-08-03	Boehringer Ingelheim Vetmedica Gmbh	Commercial scale process for production of prrsv
HRP20151031T1 (hr)	2011-02-17	2015-11-06	Boehringer Ingelheim Vetmedica Gmbh	Novi europski soj prrsv
WO2013017568A1 (en)	2011-07-29	2013-02-07	Boehringer Ingelheim Vetmedica Gmbh	INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
EP3466443B1 (en) *	2012-02-14	2020-12-16	Boehringer Ingelheim Animal Health USA Inc.	Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
KR102012109B1 (ko) *	2012-05-17	2019-08-19	조에티스 엘엘씨	이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
CN105073130A (zh)	2013-03-15	2015-11-18	勃林格殷格翰动物保健公司	猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法
US10359489B2 (en) *	2013-12-19	2019-07-23	Koninklijke Philips N.V.	Phase sensitive inversion recovery MRI with water/fat separation
ES2729838T3 (es) *	2013-12-20	2019-11-06	Boehringer Ingelheim Vetmedica Gmbh	Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo

2014
- 2014-12-19 ES ES14827219T patent/ES2729838T3/es active Active
- 2014-12-19 HU HUE19165389A patent/HUE061768T2/hu unknown
- 2014-12-19 MX MX2020010248A patent/MX2020010248A/es unknown
- 2014-12-19 EP EP19165389.8A patent/EP3591042B1/en active Active
- 2014-12-19 AU AU2014369774A patent/AU2014369774B2/en active Active
- 2014-12-19 MX MX2016007737A patent/MX375528B/es active IP Right Grant
- 2014-12-19 US US15/105,760 patent/US10010601B2/en active Active
- 2014-12-19 CN CN201480068965.2A patent/CN105829528B/zh active Active
- 2014-12-19 EP EP14827219.8A patent/EP3083947B1/en active Active
- 2014-12-19 JP JP2016540591A patent/JP6886291B2/ja active Active
- 2014-12-19 DK DK19165389.8T patent/DK3591042T5/da active
- 2014-12-19 ES ES19165389T patent/ES2940691T3/es active Active
- 2014-12-19 KR KR1020167019672A patent/KR102270344B1/ko active Active
- 2014-12-19 KR KR1020217019360A patent/KR102446025B1/ko active Active
- 2014-12-19 WO PCT/EP2014/078929 patent/WO2015092058A1/en not_active Ceased
- 2014-12-19 CA CA2930042A patent/CA2930042C/en active Active
- 2014-12-19 DK DK14827219.8T patent/DK3083947T3/da active
- 2014-12-19 EA EA201600476A patent/EA039060B1/ru unknown
2018
- 2018-06-01 US US15/995,560 patent/US10639364B2/en active Active
2019
- 2019-12-20 JP JP2019230014A patent/JP2020054380A/ja not_active Withdrawn
2021
- 2021-02-25 AU AU2021201224A patent/AU2021201224B2/en active Active
- 2021-03-24 JP JP2021049537A patent/JP7158523B2/ja active Active

Also Published As

Publication number	Publication date
JP7158523B2 (ja)	2022-10-21
US20190151432A1 (en)	2019-05-23
US10010601B2 (en)	2018-07-03
DK3591042T3 (da)	2023-04-17
JP2017502662A (ja)	2017-01-26
AU2014369774A1 (en)	2016-04-21
US10639364B2 (en)	2020-05-05
WO2015092058A1 (en)	2015-06-25
ES2940691T3 (es)	2023-05-10
DK3083947T3 (da)	2019-07-08
US20160317642A1 (en)	2016-11-03
EP3083947A1 (en)	2016-10-26
JP2021104028A (ja)	2021-07-26
KR20210080606A (ko)	2021-06-30
EP3591042A1 (en)	2020-01-08
MX2016007737A (es)	2016-09-07
DK3591042T5 (da)	2024-09-02
EP3083947B1 (en)	2019-04-03
AU2021201224B2 (en)	2023-06-15
KR20160099099A (ko)	2016-08-19
EP3591042B1 (en)	2023-01-25
JP2020054380A (ja)	2020-04-09
MX375528B (es)	2025-03-06
AU2014369774B2 (en)	2020-11-26
KR102446025B1 (ko)	2022-09-22
CN105829528A (zh)	2016-08-03
KR102270344B1 (ko)	2021-07-01
MX2020010248A (es)	2020-10-16
HUE061768T2 (hu)	2023-08-28
EA039060B1 (ru)	2021-11-29
CA2930042C (en)	2022-06-21
AU2021201224A1 (en)	2021-03-11
CA2930042A1 (en)	2015-06-25
JP6886291B2 (ja)	2021-06-16
CN105829528B (zh)	2019-10-22
EA201600476A1 (ru)	2016-11-30

Publication	Publication Date	Title
ES2729838T3 (es)	2019-11-06	Variante del virus del PRRS, clon de ADNc del virus del PRRS europeo y usos del mismo
US9187731B2 (en)	2015-11-17	PRRS virus inducing type I interferon in susceptible cells
US9315781B2 (en)	2016-04-19	Infectious CDNA clone of european PRRS virus and uses thereof
WO2015056850A1 (ko)	2015-04-23	돼지 생식기 호흡기 증후군 바이러스의 키메릭 변이주
Kimpston-Burkgren et al.	2017	Relative contribution of porcine reproductive and respiratory syndrome virus open reading frames 2–4 to the induction of protective immunity
KR100996105B1 (ko)	2010-11-22	돼지 생식기 호흡기 증후군 바이러스의 ｎ 단백질돌연변이체
TW201319083A (zh)	2013-05-16	於易感細胞內誘發第ｉ型干擾素之新穎ｐｒｒｓ病毒
EP2457583A1 (en)	2012-05-30	Nucleic acids encoding PRRSV GP5-ecto and M protein
EA044385B1 (ru)	2023-08-23	Вариант вируса ррсс, клон кднк вируса ррсс европейского типа и их применение
Sun	2017	Study of a Synthetic Porcine Reproductive and Respiratory Syndrome Virus Strain as a Vaccine Candidate
Ma	2018	A NOVEL INTERFERON-INDUCING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS STRAIN: CHARACTERIZATION AND VACCINE DEVELOPMENT
Vu et al.	2016	A synthetic porcine reproductive and respiratory syndrome unprecedented levels of heterologous protection
FOUR	2013	Dong Sun, Won-Il Kim, Yong-Il Cho, Hai Hoang, Kyoung-Jin Yoon